Evidence map›Paper›PMID 36929131›Full record

ArticleAutism research : official journal of the International Society for Autism Research2023

Evaluation of clinical assessments of social abilities for use in autism clinical trials by the autism biomarkers consortium for clinical trials.

Susan Faja, Maura Sabatos-DeVito, Aksheya Sridhar, Jocelyn L Kuhn, Julia I Nikolaeva, Catherine A Sugar, Sara Jane Webb, Raphael A Bernier, Linmarie Sikich, Gerhard Hellemann and 12 more

Abstract read
In one paragraph

Article in Autism research : official journal of the International Society for Autism Research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Parsing evoked and induced gamma response differences in Autism: A visual evoked potential study.Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Susan FajaDepartment of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.ORCID 0000-0001-6876-3643
Maura Sabatos-DeVitoDuke Center for Autism and Brain Development, Duke University, Durham, North Carolina, USA.
Aksheya SridharDepartment of Psychology, Michigan State University, East Lansing, Michigan, USA.
Jocelyn L KuhnDepartment of Pediatrics, Boston University School of Medicine, Boston, Massachusetts, USA.
Julia I NikolaevaDepartment of Communication Sciences and Disorders, Northwestern University, Evanston, Illinois, USA.
Catherine A SugarDepartment of Biostatistics, University of California Los Angeles, Los Angeles, California, USA.
Sara Jane WebbCenter for Child Health, Behavior and Development, Seattle Children's Research Institute, Seattle, Washington, USA.
Raphael A BernierDepartment of Psychiatry & Behavioral Science, University of Washington School of Medicine, Seattle, Washington, USA.
Linmarie SikichDepartment of Psychiatry & Behavioral Sciences, Duke University, Durham, North Carolina, USA.
Gerhard HellemannDepartment of Biostatistics, University of Alabama at Birmingham, Birmingham, Alberta, USA.
Damla SenturkDepartment of Biostatistics, University of California Los Angeles, Los Angeles, California, USA.
Adam J NaplesYale University, Child Study Center, New Haven, Connecticut, USA.
Frederick ShicCenter for Child Health, Behavior and Development, Seattle Children's Research Institute, Seattle, Washington, USA.ORCID 0000-0002-9040-1259
April R LevinDepartment of Neurology, Boston Children's Hospital, Boston, Massachusetts, USA.
Helen A SeowYale Center for Clinical Investigation, Yale University, New Haven, Connecticut, USA.
James D DziuraDepartment of Emergency Medicine, Yale University, New Haven, Connecticut, USA.
Shafali S JesteDepartment of Pediatrics and Neurology, Children's Hospital, Los Angeles, California, USA.
Katarzyna ChawarskaYale University, Child Study Center, New Haven, Connecticut, USA.ORCID 0000-0002-1445-6346
Charles A NelsonDepartment of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.
Geraldine DawsonDuke Center for Autism and Brain Development, Duke University, Durham, North Carolina, USA.
James C McPartlandYale University, Child Study Center, New Haven, Connecticut, USA.
Autism Biomarkers Consortium for Clinical Trials

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
The Autism Biomarkers Consortium for Clinical TrialsU19MH108206 · NIMH · YALE UNIVERSITY · PI KLEINHANS, NATALIA M · 2015 to 2024
$68.8M
Mechanisms of Brain Dysmorphology in MN1 C-Terminal Truncation Syndrome, a Novel Intellectual Developmental Disability Disorder P50HD103524 · NICHD · UNIVERSITY OF WASHINGTON · PI DANIEL DOHERTY · 2020 to 2026
$9.9M
Genetic Analysis and Manipulation Core (GAEC)P50HD105351 · NICHD · BOSTON CHILDREN'S HOSPITAL · PI SCOTT Loren POMEROY, MUSTAFA SAHIN · 2021 to 2026
$9.4M
NCATS NIH HHS UL1 TR001863NICHD NIH HHS P50 HD103524NICHD NIH HHS P50 HD105351NIMH NIH HHS U19 MH108206
6 · The paper itself

Abstract

Clinical trials in autism spectrum disorder (ASD) often rely on clinician rating scales and parent surveys to measure autism-related features and social behaviors. To aid in the selection of these assessments for future clinical trials, the Autism Biomarkers Consortium for Clinical Trials (ABC-CT) directly compared eight common instruments with respect to acquisition rates, sensitivity to group differences, equivalence across demographic sub-groups, convergent validity, and stability over a 6-week period. The sample included 280 children diagnosed with ASD (65 girls) and 119 neurotypical children (36 girls) aged from 6 to 11 years. Full scale IQ for ASD ranged from 60 to 150 and for neurotypical ranged from 86 to 150. Instruments measured clinician global assessment and autism-related behaviors, social communication abilities, adaptive function, and social withdrawal behavior. For each instrument, we examined only the scales that measured social or communication functioning. Data acquisition rates were at least 97.5% at T1 and 95.7% at T2. All scales distinguished diagnostic groups. Some scales significantly differed by participant and/or family demographic characteristics. Within the ASD group, most clinical instruments exhibited weak (≥ |0.1|) to moderate (≥ |0.4|) intercorrelations. Short-term stability was moderate (ICC: 0.5-0.75) to excellent (ICC: >0.9) within the ASD group. Variations in the degree of stability may inform viability for different contexts of use, such as identifying clinical subgroups for trials versus serving as a modifiable clinical outcome. All instruments were evaluated in terms of their advantages and potential concerns for use in clinical trials.

Indexed as

Autism Spectrum DisorderAutistic DisorderBiomarkersChildCommunicationFemaleHumansSocial SkillsBiomarkersautism spectrum disorderbiomarkersclinical trialsmeasurementstabilityvalidity

Identifiers

PMID36929131
PMCPMC10192100

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.